155 related articles for article (PubMed ID: 5067882)
1. [Possibilities and limitations of hormone therapy between puberty and the menopause].
Kopera H
Munch Med Wochenschr; 1972 Apr; 114(16):754-60. PubMed ID: 5067882
[No Abstract] [Full Text] [Related]
2. Hormonal replacement therapy--cardiovascular disease.
Silfverstolpe G; Crona N
Acta Obstet Gynecol Scand Suppl; 1986; 134():93-5. PubMed ID: 3028030
[No Abstract] [Full Text] [Related]
3. [Hormonal substitution after menopause--advantages and risks].
Bengtsson C
Lakartidningen; 1990 Dec; 87(50):4331-3. PubMed ID: 2280638
[No Abstract] [Full Text] [Related]
4. [Single monthly injection for contraception].
Artner J; Friedrich F
Geburtshilfe Frauenheilkd; 1970 Jun; 30(6):554-64. PubMed ID: 5475938
[No Abstract] [Full Text] [Related]
5. [The role of progestin in menopausal hormonal replacement therapy].
Kauppila A
Duodecim; 1996; 112(12):1097-103. PubMed ID: 10593011
[No Abstract] [Full Text] [Related]
6. [10 years of research using steroids as controllers of ovulation].
Martínez-Manautou J
Gac Med Mex; 1968 Dec; 98(12):1560-75. PubMed ID: 4182066
[No Abstract] [Full Text] [Related]
7. Hormone therapy. An update on risks and benefits.
Mayo Clin Womens Healthsource; 2009 Mar; Suppl():1-8. PubMed ID: 19405167
[No Abstract] [Full Text] [Related]
8. Risks of venous thromboembolism with various hormonal contraceptives.
Allan GM; Koppula S
Can Fam Physician; 2012 Oct; 58(10):1097. PubMed ID: 23064919
[No Abstract] [Full Text] [Related]
9. Hormone therapy for the menopause.
Gambrell RD; Greenblatt RB
Geriatrics; 1981 Jul; 36(7):53-61. PubMed ID: 7239166
[No Abstract] [Full Text] [Related]
10. [Our experience with Cyclofenil in the stimulation of ovulation].
Bernard I; Grelet MC
Bord Med; 1970 Nov; 3(11):2717-20 passim. PubMed ID: 5510147
[No Abstract] [Full Text] [Related]
11. Guidelines for hormone treatment of women in the menopausal transition and beyond.
Naftolin F; Schneider HP; Sturdee DW;
Maturitas; 2005 May; 51(1):15-20. PubMed ID: 15883104
[No Abstract] [Full Text] [Related]
12. Pros and cons of estrogen-replacement therapy.
Quigley MM; Hammond CB
N Engl J Med; 1980 Jan; 302(5):297. PubMed ID: 7350488
[No Abstract] [Full Text] [Related]
13. [Ovulation inhibition in the treatment of androgenic alopecia in woemn].
Zaun H
Hautarzt; 1971 Dec; 22(12):549. PubMed ID: 5158336
[No Abstract] [Full Text] [Related]
14. Nursing Mirror clinical forum 7. Hormone replacement therapy.
Fish S
Nurs Mirror; 1983 Aug; 157(6):suppl i-vii. PubMed ID: 6554776
[No Abstract] [Full Text] [Related]
15. [Is estro-progestative supplementation after menopause a youth drug?].
Faquer de Moustier B
Rev Prat; 1989 Feb; 39(5):405-7. PubMed ID: 2704956
[No Abstract] [Full Text] [Related]
16. Oral contraceptive agents and the glucose tolerance problem.
Cohn RE
Pa Med; 1971 Jan; 74(1):62-4. PubMed ID: 5540284
[No Abstract] [Full Text] [Related]
17. The use of Ro 4-8347 in amenorrhea and anovulation.
Polishuk WZ; Schechter A; Kozminski T
Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):565-74. PubMed ID: 5510180
[No Abstract] [Full Text] [Related]
18. Pros and cons of estrogen-replacement therapy.
Korenman SG
N Engl J Med; 1980 Jan; 302(5):297. PubMed ID: 7350487
[No Abstract] [Full Text] [Related]
19. [Gestagens containing small doses of highly active progestagens].
Stĕrba R
Cesk Farm; 1968 Mar; 17(3):150-4. PubMed ID: 5666306
[No Abstract] [Full Text] [Related]
20. So far, victories are few as breast cancer patients sue Wyeth over hormone therapy.
Twombly R
J Natl Cancer Inst; 2007 Dec; 99(24):1828-9, 1835. PubMed ID: 18073368
[No Abstract] [Full Text] [Related]
[Next] [New Search]
